Mesoblast (MESO) Shares Outstanding (2014 - 2025)
Mesoblast (MESO) posted quarterly Shares Outstanding (Entity) of $129.0 for Q4 2025, up 13.16% year-on-year from $114.0 in Q4 2024, and down 100.0% on a QoQ basis from $120.8 million in Q2 2025.
Mesoblast (MESO) Shares Outstanding (2014 - 2025) Analysis & Trends
Mesoblast (MESO) has reported Shares Outstanding (Entity) for 11 consecutive years, with $129.0 the latest figure, recorded in Q4 2025.
- Quarterly Shares Outstanding (Entity) rose 13.16% year-over-year to $129.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $129.0 (up 13.16% YoY) and the FY2025 annual result came in at $120.8 million, up 121999206.06% from the prior year.
- Shares Outstanding (Entity) fell to $129.0 in Q4 2025 per MESO's latest filing, from $120.8 million in the prior quarter.
- Over the last five years, Shares Outstanding (Entity) for MESO reached as high as $120.8 million in Q2 2025 and fell as low as $60.0 in Q1 2021.
- A 5-year average of $8.1 million and a median of $74.0 in 2022 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2024 — Shares Outstanding (Entity) slumped 32.94% — and 2025, when it jumped 121999206.06%.
- Year by year, Shares Outstanding (Entity) stood at $65.0 in 2021, then gained by 13.85% to $74.0 in 2022, then jumped by 129.73% to $170.0 in 2023, then sank by 32.94% to $114.0 in 2024, then increased by 13.16% to $129.0 in 2025.
- According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $129.0, $120.8 million, and $114.0 for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 6,012.74 Bn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 47.82 Bn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.44 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 11.23 Bn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 254.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 400.00 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 62.19 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 198.10 Mn |
| 10 | Mesoblast | 2.08 Bn | 1.95 Bn | - | 1.29 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.29 Bn |
| Jun 30, 2025 | 1.21 Bn |
| Dec 31, 2024 | 1.14 Bn |
| Jun 30, 2024 | 986.70 Mn |
| Dec 31, 2023 | 851.46 Mn |
| Jun 30, 2023 | 369.52 Mn |
| Mar 31, 2023 | 368.29 Mn |
| Dec 31, 2022 | 368.29 Mn |
| Sep 30, 2022 | 348.04 Mn |
| Jun 30, 2022 | 324.45 Mn |
| Mar 31, 2022 | 324.78 Mn |
| Dec 31, 2021 | 324.05 Mn |
| Sep 30, 2021 | 324.02 Mn |
| Jun 30, 2021 | 302.53 Mn |
| Mar 31, 2021 | 302.22 Mn |
| Dec 31, 2020 | 293.18 Mn |
| Sep 30, 2020 | 291.24 Mn |
| Jun 30, 2020 | 264.41 Mn |
| Mar 31, 2020 | 268.83 Mn |
| Dec 31, 2019 | 267.21 Mn |